CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 254 filers reported holding CLOVIS ONCOLOGY INC in Q4 2017. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $22,000 | -76.3% | 11,110 | -67.7% | 0.00% | -50.0% |
Q4 2021 | $93,000 | -95.2% | 34,431 | -89.6% | 0.00% | -94.4% |
Q2 2021 | $1,920,000 | +879.6% | 331,063 | +1088.0% | 0.04% | +800.0% |
Q1 2021 | $196,000 | +142.0% | 27,867 | +133.5% | 0.00% | 0.0% |
Q2 2020 | $81,000 | -88.3% | 11,934 | -82.1% | 0.00% | -87.1% |
Q4 2019 | $695,000 | -13.2% | 66,634 | +23.7% | 0.03% | +34.8% |
Q2 2019 | $801,000 | +100.8% | 53,849 | +817.7% | 0.02% | +130.0% |
Q4 2017 | $399,000 | +50.0% | 5,868 | -57.7% | 0.01% | +42.9% |
Q1 2016 | $266,000 | -96.6% | 13,858 | -93.8% | 0.01% | -96.8% |
Q4 2015 | $7,875,000 | +1972.4% | 225,000 | +5346.6% | 0.22% | +1600.0% |
Q3 2015 | $380,000 | – | 4,131 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 3,402,781 | $231,389,000 | 9.96% |
Versant Venture Management, LLC | 101,855 | $6,926,140,000 | 7.29% |
Avoro Capital Advisors LLC | 1,102,884 | $74,996,000 | 4.86% |
Redmile Group, LLC | 1,320,027 | $89,762,000 | 3.90% |
NEXTHERA CAPITAL LP | 233,200 | $15,858,000 | 2.92% |
Iguana Healthcare Management, LLC | 60,000 | $4,080,000 | 2.66% |
HealthCor Management, L.P. | 973,840 | $66,221,000 | 2.16% |
Casdin Capital, LLC | 127,500 | $8,670,000 | 2.11% |
Prosight Management, LP | 40,000 | $2,720,000 | 2.00% |
Camber Capital Management LP | 600,000 | $40,800,000 | 2.00% |